Correction for Poon et al., Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. . Proc Natl Acad Sci U S A 2024;121:e2420080121.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction for Poon et al., Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proc Natl Acad Sci U S A 2024;121:e2420080121.
PMID: 39432800